RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Bio-Techne (NASDAQ:TECH) but lowered the price target from $85 to $75.
February 02, 2024 | 3:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RBC Capital has maintained a 'Sector Perform' rating on Bio-Techne but reduced the price target from $85 to $75.
The reduction in price target by RBC Capital suggests a less optimistic outlook on Bio-Techne's stock price in the short term, potentially leading to a negative impact on investor sentiment and the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100